Lv1
48 积分 2024-11-05 加入
Abstract 579: A novel nanobody-based radionuclide drug conjugate (RDC) platform through introducing a human serum albumin (HSA) binder by the intelligent ligase-dependent conjugation (iLDC) technology: an innovative and versatile approach for next-generation RDCs with enhanced pharmacokinetics and druggability
12天前
已关闭
Nanobodies Open New Avenues in Cancer Treatment: From Molecular Engineering to Therapeutic Platforms
12天前
已完结
Absorption, distribution, metabolism, and excretion of tirzepatide in humans, rats, and monkeys
1个月前
已完结
Evaluation of in vitro liver models and non-human primates for predicting ADAR RNA editing efficiency in human liver
2个月前
已完结
Discovery of a novel deaminated metabolite of a single-stranded oligonucleotide in vivo by mass spectrometry
2个月前
已完结
Quantification of treprostinil concentration in rat and human using a novel validated and rapid liquid chromatography-tandem mass spectrometry method: Experimental and clinical applications in ischemia-reperfusion injury
2个月前
已完结
Nonclinical pharmacokinetics of a new nonpeptide V2 receptor antagonist, tolvaptan
3个月前
已完结
Regional intestinal permeability of the oral peptide permeation enhancer sodium salcaprozate (SNAC) in healthy volunteers
3个月前
已完结
Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
3个月前
已完结
Population Pharmacokinetic Analysis of an Octreotide Depot (CAM2029) in the Treatment of Acromegaly
5个月前
已完结
皖公网安备34019202002308
